Transbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung Cancer

NARecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

October 11, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

October 31, 2027

Conditions
Stage IA Lung Cancer
Interventions
DEVICE

The disposable pulmonary radiofrequency ablation catheter and pulmonary radiofrequency ablation system

Procedure: In combination with guided bronchoscopy and CBCT, the ablation catheter is placed in the target lesion. CBCT confirms the tool in the lesion, adjusts the position of the ablation catheter, and monitors the extent of ablation.

DEVICE

The disposable percutaneous radiofrequency ablation needle and pulmonary radiofrequency ablation system

Procedure: The ablation needle is punctured into the lesion under CT guidance. The extent of the ablation is monitored by CT.

Trial Locations (1)

200030

RECRUITING

Shanghai Chest Hospital, Shanghai

All Listed Sponsors
collaborator

Shanghai Chest Hospital

OTHER

lead

Hangzhou Broncus Medical Co., Ltd.

INDUSTRY

NCT06052098 - Transbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung Cancer | Biotech Hunter | Biotech Hunter